Affordable Access

Klotho and the treatment of human malignancies

Authors
  • Sachdeva, A
  • Gouge, J
  • Kontovounisios, C
  • Nikolaou, S
  • Ashworth, A
  • Lim, K
  • Chong, I
Publication Date
Jun 16, 2020
Source
UPCommons. Portal del coneixement obert de la UPC
Keywords
License
Green
External links

Abstract

Klotho was first discovered as an anti-ageing protein linked to a number of age-related disease processes, including cardiovascular, renal, musculoskeletal, and neurodegenerative conditions. Emerging research has also demonstrated a potential therapeutic role for Klotho in cancer biology, which is perhaps unsurprising given that cancer and ageing share similar molecular hallmarks. In addition to functioning as a tumour suppressor in numerous solid tumours and haematological malignancies, Klotho represents a candidate therapeutic target for patients with these diseases, the majority of whom have limited treatment options. Here, we examine contemporary evidence evaluating the anti-neoplastic effects of Klotho and describe the modulation of downstream oncogenic signalling pathways, including Wnt/β-catenin, FGF, IGF1, PIK3K/AKT, TGFβ, and the Unfolded Protein Response. We also discuss possible approaches to developing therapeutic Klotho and consider technological advances that may facilitate the delivery of Klotho through gene therapy.

Report this publication

Statistics

Seen <100 times